DavidIngbarMD
Pulmonology • Minneapolis, MNCritical Care Medicine
Professor, Medicine, and Assistant Dean for Faculty Development & Mentoring; University of Minnesota Medical School
Dr. Ingbar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MHealth Clinic & Surgery Center
University Of Minnesota Physicians
Minneapolis, MN 55455Phone+1 612-626-6100Fax+1 612-625-2174
Summary
- Dr. David Ingbar is a physician scientist Pulmonologist- Intensivist Professor of Medicine and past Director of the Pulmonary, Allergy, Critical Care & Sleep Division at the University of Minnesota. He is Assistant Dean for Faculty Development and Mentoring, past President of the American Thoracic Society, serves on NHLBI Council and a US Best Doctor by Castle Connolly for>15 consecutive years.
Education & Training
Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1985
University of WashingtonResidency, Internal Medicine, 1978 - 1982
Harvard Medical SchoolClass of 1978
Certifications & Licensure
MN State Medical License 1991 - 2025
CT State Medical License 1982 - 1991
WA State Medical License 1979 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2019, 2021-2022, 2029
- NHLBI Council member NIH, 2021-2023
- NHLBI Scientific Advisory Council member National Institutes of Heakth, 2020-2022
- Join now to see all
Clinical Trials
- Treatment of ARDS With Instilled T3 Start of enrollment: 2019 Oct 21
Publications & Presentations
PubMed
- 75 citationsTerbutaline stimulates alveolar fluid resorption in hyperoxic lung injuryJoseph M. Lasnier, O. Douglas Wangensteen, Laura S. Schmitz, Cynthia R. Gross, David H. Ingbar
Journal of Applied Physiology. 1996-10-01 - 18 citationsNongenomic actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine. Focus on "L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-ac...Maneesh Bhargava, Jianxun Lei, David H. Ingbar
American Journal of Physiology. Cell Physiology. 2009-03-18 - 17 citationsImmediate Impact of the COVID-19 Pandemic on CTSA TL1 and KL2 Training and Career DevelopmentWayne T. McCormack, Miriam A. Bredella, David H. Ingbar, Rebecca D. Jackson, Emma A. Meagher
Journal of Clinical and Translational Science. 2020-06-29
Other
- Massive hemoptysis: CausesIngbar DH
http://www.uptodate.com/contents/massive-hemoptysis-causes
UpToDate, Wolters Kluwer Health - 2012-07-09 - Massive hemoptysis: Initial managementIngbar DH
http://www.uptodate.com/contents/massive-hemoptysis-initial-management
UpToDate, Wolters Kluwer Health - 2012-12-06 - Overview of massive hemoptysisIngbar DH
http://www.uptodate.com/contents/overview-of-massive-hemoptysis
UpToDate, Wolters Kluwer Health - 2012-07-09
Press Mentions
Doctor Warns Poor Air Quality Can Have Deadly Consequences for High-Risk PeopleJuly 21st, 2021- Smoky Air in Minnesota Can Bring Some Health Impacts, Doctors WarnJuly 21st, 2021
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19March 10th, 2021- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
